The recent analysis by Heather Roulston from MMIT highlights key trends in medical benefit contracting, emphasizing the growing adoption of value-based agreements (VBAs) among manufacturers and payers. By late 2022, over half of the commercial lives reported some level of contracting for medical benefit products, with significant growth expected in areas like oncology and rare diseases. VBA utilization is also increasing but varies widely by therapeutic area; currently, it’s most common in rare diseases and respiratory disorders. Additionally, site-of-care management remains crucial, with many payers utilizing preferred sites while still covering some treatments at non-preferred locations. The ongoing consolidation among pharmacy benefit managers (PBMs) is anticipated to further influence contracting dynamics.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.drugchannels.net/2023/04/key-trends-in-medical-benefit.html
